CIK 0001540159
- Non-accelerated filer
- Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 905-475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Grant or award Director acquired 140,625 shares (grant or award)
- 4/A Grant or award President acquired 1,827 shares (grant or award)
- 4/A Grant or award Director acquired 2,436 shares (grant or award)
- 4/A Grant or award Director acquired 8,524 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 9,255 shares (grant or award)
- 4 Grant or award Director acquired 1,218 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 1,218 shares (grant or award)
- 4 Grant or award Director acquired 2,436 shares (grant or award)
- 4 Open-market buy Director bought 140,625 shares at $3.20 ($450,000)
- 4 Open-market buy Director bought 2,436 shares at $4.11 ($10,012)
- 4 Open-market buy Director bought 8,524 shares at $4.11 ($35,034)
- 4 Open-market buy President bought 1,827 shares at $4.11 ($7,509)
Page 9 of 14 · 261 filings